Table 2. Outcome estimates—aortic valve replacement.

Variable	Mechanical AVR		Bioprosthetic AVR		Ross
Variable	Pooled estimate	95% CI	Pooled estimate	95% CI	Pooled estimate	95% CI
Early <30 days (%)
Mortality	3.15	2.37–4.21	3.3	2.39–4.55	2.01	1.44–2.82
Re-exploration for bleeding	5.15	2.57–11.81	4.08	1.96–8.51
Peripheral bleeding	0.41	0.15–1.09
Thromboembolism			1.6	0.89–2.87
Stroke	1.55	0.98–2.46
Transient ischemic attack	0.81	0.38–1.72
Valve thrombosis	0.3	0.09–1.05
Myocardial infarction	0.87	0.40–1.87
Endocarditis	0.43	0.16–1.13
DSI/mediastinitis	2.48	1.56–3.94
Pacemaker implantation	3.53	2.47–5.05
Late >30 days (%/y)
Overall mortality	1.55	1.25–1.92	2.39	1.13–2.94	0.59	0.46–0.76
Cardiac	0.95	0.71–1.27	0.96	0.71–1.29	0.24	0.17–0.33
Valve-related	0.6	0.44–0.81	0.6	0.37–0.98	0.21	0.14–0.32
SUUD	0.37	0.26–0.54	0.3	0.12–0.76	0.16	0.10–0.25
Valve-related reoperation	0.51	0.37–0.71	1.82	1.31–2.52	1.2	1.01–1.42
Ross autograft					0.83	0.68–1.01
Ross RVOT					0.47	0.37–0.59
Hemorrhage	0.85	0.65–1.12	0.22	0.16–0.32	0.1	0.01–0.67
Thromboembolism	0.9	0.68–1.21	0.53	0.42–0.67	0.17	0.11–0.27
Valve thrombosis	0.14	0.08–0.25	0.07	0.02–0.20	0.03	0.01–0.09
SVD	0.00	0.00–0.00	1.59	1.21–2.10
NSVD	0.39	0.21–0.76	0.24	0.10–0.58
Endocarditis	0.41	0.29–0.57	0.48	0.37–0.62
Ross autograft					0.18	0.09–0.39
Ross RVOT					0.14	0.09–0.21
Pacemaker implantation					0.25	0.05–1.17

AVR, aortic valve replacement; Ross, the Ross procedure; CI, confidence interval; DSI, deep sternal wound infection; RVOT, right ventricular outflow tract.